Amantadine Hydrochloride Suppliers & Bulk Manufacturers

Available Forms: Tablets, Capsules

Available Strengths: 100 mg, 200 mg, 129 mg, 137 mg

Reference Brands: Symmetrel (USA), Gocovri (USA)

Category: Neurology

Amantadine Hydrochloride is available in Tablets, Capsules and strengths such as 100 mg, 200 mg, 129 mg, 137 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Amantadine Hydrochloride is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Amantadine Hydrochloride can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Amantadine Hydrochloride is an oral medication with dual antiviral and antiparkinsonian activity. It is primarily used to manage motor symptoms and dyskinesia associated with Parkinson’s disease, helping to improve movement control and reduce involuntary muscle movements. While it was originally developed to prevent and treat influenza A virus infections by blocking viral replication and the ability of the virus to infect cells, its use for influenza A is now largely limited due to widespread resistance.

Amantadine works by modulating dopamine release and reuptake in the central nervous system, which alleviates motor deficits in Parkinson’s disease. It is available in immediate-release tablets, extended-release capsules, and oral solution forms to suit different treatment regimens. Commonly marketed under brand names such as Symmetrel and Gocovri, amantadine hydrochloride is prescribed under medical supervision, with careful dose adjustments to optimize efficacy and minimize side effects. The drug offers a well-established therapy option for managing Parkinsonian symptoms, particularly dyskinesia, and remains an important part of neurological care in patients with movement disorders.